The coronavirus pandemic has been one of history’s deadliest crises to have hit the world and naturally, the market for its vaccines has become the hotbed for investors. Over the past year or so, many companies have come up with their own vaccines and...
For the past couple of years, biotech firm CytoDyn (OTCMKTS:CYDY) has come into prominence due to its work with leronlimab, which is known to work against a range of conditions. On Wednesday, the CytoDyn stock was in action but it actually recoded a decline...
Read original article here. Collection Sites launched multi-week custom testing solutions for a high-school athletics department in Redlands, California and a film production company in Los Angeles as part of its new business-focused sales strategy. Further, Medivolve announces an investor webinar Tuesday, March 23rd at 1 pm ET TORONTO, March 18,...
Read original article here. As part of its telehealth strategy, Medivolve has acquired a pharmacy to better serve Collection Sites telehealth patients as the program launches. Further, Medivolve will host an investor webinar Tuesday, March 23rd at 1 pm ET TORONTO, March 16, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV;...
Over the course of the past few months, many biotech companies have seen their stocks soar on the back of their efforts to create medicines or vaccines for the coronavirus pandemic. One such stock if Ibio Inc (NYSEAMERICAN:IBIO), which has gained as much as 490% so far as it...